compound tirzepatide still available Mounjaro and Zepbound Are No Longer in Shortage, F.D.A. Says Compounded Tirzepatide for Weight Loss

This modest early loss primarily reflects reduced caloric intake from appetite suppression rather than significant metabolic changes

Tirzepatide, a weight loss medication developed by Eli Lilly, has shown promise in treating obesity by inducing significant body weight loss compared to other weight loss drugs

With the effects seen of the GLP-1 family of drugs on preventing kidney damage in diabetes, liver disease (non-alcoholic or metabolic-associated steatosis, NASH/MASH), and addiction, this drug class is exceeding all expectations

These effects lead to improved glycaemic control and significant weight loss in many patients

Easy to book online, prompt at appointments, and a results-focused approach